We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Full Fed. Circ. Urged To Rehear 'Blocking Patents' Ruling

Law360 (October 25, 2018, 4:16 PM EDT) -- Acorda Therapeutics Inc. urged the full Federal Circuit on Wednesday to reconsider an earlier ruling invalidating several patents covering its flagship multiple sclerosis drug Ampyra, arguing that the decision “radically expands”...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.